Cormedix Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cormedix Inc. on August 10, 2017, covering events occurring on August 9, 2017. The company is incorporated in Delaware and maintains its principal executive offices in Bedminster, New Jersey.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
On August 9, 2017, the company amended its Amended and Restated Certificate of Incorporation following stockholder approval at a special meeting on August 8, 2017. The amendment resulted in the following changes to authorized capital:
- Total authorized shares of capital stock increased from 82,000,000 to 162,000,000.
- Authorized shares of common stock increased from 80,000,000 to 160,000,000.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to disclose the amendment to the Articles of Incorporation.
Investor Verification Checklist
- Verify the effective date of the Certificate of Amendment filed with the Delaware Secretary of State.
- Confirm the exact number of authorized common shares (160,000,000) versus total capital stock (162,000,000) to understand the remaining authorized preferred or other stock classes.
- Review the company's subsequent filings to determine if shares were issued under the new authorization.